A detailed history of Black Rock Inc. transactions in Novavax Inc stock. As of the latest transaction made, Black Rock Inc. holds 11,846,512 shares of NVAX stock, worth $161 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,846,512
Previous 9,428,531 25.65%
Holding current value
$161 Million
Previous $45.1 Million 232.78%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$3.89 - $20.97 $9.41 Million - $50.7 Million
2,417,981 Added 25.65%
11,846,512 $150 Million
Q1 2024

May 10, 2024

BUY
$3.76 - $6.02 $3.73 Million - $5.97 Million
992,352 Added 11.76%
9,428,531 $45.1 Million
Q4 2023

Feb 13, 2024

BUY
$4.8 - $7.67 $6.57 Million - $10.5 Million
1,369,298 Added 19.38%
8,436,179 $40.5 Million
Q3 2023

Nov 13, 2023

BUY
$6.81 - $9.74 $491,055 - $702,331
72,108 Added 1.03%
7,066,881 $51.2 Million
Q2 2023

Aug 11, 2023

BUY
$6.67 - $9.52 $14.8 Million - $21.1 Million
2,220,039 Added 46.5%
6,994,773 $52 Million
Q1 2023

May 12, 2023

SELL
$5.76 - $12.48 $77,351 - $167,593
-13,429 Reduced 0.28%
4,774,734 $33.1 Million
Q4 2022

Feb 13, 2023

BUY
$8.86 - $25.04 $4.09 Million - $11.6 Million
461,747 Added 10.67%
4,788,163 $49.2 Million
Q3 2022

Nov 14, 2022

BUY
$18.2 - $76.12 $1.24 Million - $5.17 Million
67,975 Added 1.6%
4,326,416 $78.7 Million
Q2 2022

Aug 12, 2022

SELL
$36.28 - $75.29 $9.34 Million - $19.4 Million
-257,364 Reduced 5.7%
4,258,441 $219 Million
Q1 2022

May 12, 2022

BUY
$69.73 - $142.9 $8.41 Million - $17.2 Million
120,644 Added 2.74%
4,515,805 $333 Million
Q4 2021

Feb 10, 2022

SELL
$134.56 - $217.97 $71.5 Million - $116 Million
-531,628 Reduced 10.79%
4,395,161 $629 Million
Q3 2021

Nov 09, 2021

BUY
$177.8 - $270.58 $66 Million - $100 Million
371,369 Added 8.15%
4,926,789 $1.02 Billion
Q2 2021

Aug 11, 2021

BUY
$121.0 - $257.67 $551 Million - $1.17 Billion
4,555,420 New
4,555,420 $967 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $1.06B
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.